Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Exe V-P Global Srvs & CIO | May 02, 2012 | May 04, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date May 02, 2012 · Filed May 04, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2015-05-02 | Direct | 5,090 |
Reported balance
After 2012-05-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2012-05-02 · Grant · Acquired 5,090 · Balance 5,090 F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.29 · Expires 2022-05-01 | Direct | 73,126 |
Reported balance
After 2012-05-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2012-05-02 · Grant · Acquired 73,126 · Balance 73,126 F4: The option vests in three equal annual installments beginning May 2, 2013. |
| Common StockSEC Table I · non-derivative | Direct | 79,829.149 |
Reported balance
Holding disclosure · report date 2012-05-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 79,829.149 F1: Holdings include shares acquired in dividend reinvestment transactions. |
| Common Stock - 401(k) PlanSEC Table I · non-derivative | IndirectBy 401(k) | 3,212.2852 |
Reported balance
Holding disclosure · report date 2012-05-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,212.2852 F2: Includes shares acquired and dividends earned through April 6, 2012 in the MSD Employee Savings and Security Plan, a 401(k) plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Includes shares acquired and dividends earned through April 6, 2012 in the MSD Employee Savings and Security Plan, a 401(k) plan.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: The option vests in three equal annual installments beginning May 2, 2013.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IntraLinks Holdings, Inc.
Report date January 19, 2017 · Filed January 19, 2017
Section 16 reporting ended · disclosed 2017-01-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-01-19 transaction · row 1
1 source rowRow 1 · 2017-01-19 · Other · Disposed 82,760 · Balance 0 F1: Disposed of pursuant to the closing, on January 19, 2017, of a cash tender offer by GL Merger Sub, Inc., a wholly owned subsidiary of Synchronoss Technologies, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the closing, on January 19, 2017, of a cash tender offer by GL Merger Sub, Inc., a wholly owned subsidiary of Synchronoss Technologies, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 19, 2017 Filed Jan 19, 2017 17:30 UTC | IntraLinks Holdings, Inc. IL · Entity 179553 | OtherCommon Stock | 82,760 | $13.00 | $1,075,880.00 |
DisclosureSEC source: 0001488075-17-000045 · wf-form4_148486499121293.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of pursuant to the closing, on January 19, 2017, of a cash tender offer by GL Merger Sub, Inc., a wholly owned subsidiary of Synchronoss Technologies, Inc. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 73,126 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011190 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,126 Underlying: Common Stock · 73,126 shares Expires 2022-05-01 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 5,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011190 · doc4.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090 Underlying: Common Stock · 5,090 shares Expires 2015-05-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRSU - Leader Shares · Derivative | 15,000 | $38.27 | $574,050.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · derivative · entry 7 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 11,700 | $38.27 | $447,759.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · derivative · entry 6 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 6,896 | $38.27 | $263,909.92 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,829.149 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 4,253 | $38.27 | $162,762.31 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,725.149 Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 2 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,978.149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010298 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,278.149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2012 Filed Mar 1, 2012 20:37 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 8,709 | $38.38 | $334,251.42 |
DisclosureSEC source: 0001225208-12-006225 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,832.965 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/27/09. Performance shares were paid out at 117 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 74,627 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013368 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,627 Underlying: Common Stock · 74,627 shares Expires 2021-05-03 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:43 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013368 · doc4.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,470 Underlying: Common Stock · 5,470 shares Expires 2014-05-04 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 9,750 | $32.19 | $313,852.50 |
DisclosureSEC source: 0001225208-11-007805 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,750 shares Expires 2011-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 3,545 | $32.19 | $114,113.55 |
DisclosureSEC source: 0001225208-11-007805 · doc4.xml · nonDerivative · entry 2 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,590.592 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 20:08 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 9,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-007805 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,135.592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2011 Filed Feb 24, 2011 17:02 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 7,511 | $32.34 | $242,905.74 |
DisclosureSEC source: 0001225208-11-007025 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,385.592 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 2/29/08. Performance shares were paid out at 122 percent of target awards. F2 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:35 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 78,031 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012620 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,031 Underlying: Common Stock · 78,031 shares Expires 2020-05-06 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 20:35 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 13,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012620 · doc4.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,437 Underlying: Common Stock · 13,437 shares Expires 2013-05-07 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 19:58 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionRestricted Stock Unit · Derivative | 7,650 | $37.27 Strike: $0.00 | $285,115.50 |
DisclosureSEC source: 0001225208-10-007076 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,650 shares Expires 2010-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 19:58 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 2,781 | $37.27 | $103,647.87 |
DisclosureSEC source: 0001225208-10-007076 · doc4.xml · nonDerivative · entry 2 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,703.8585 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| March 02, 2010 Filed Mar 4, 2010 19:58 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 7,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-007076 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,484.8585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2010 Filed Jan 26, 2010 19:35 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 5,667 | $37.72 | $213,759.24 |
DisclosureSEC source: 0001225208-10-002269 · doc4.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,834.8585 F1 · shares: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/02/2007. Performance shares were paid out at 120 percent of target awards. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 62,400 | $0.00 Strike: $23.45 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 14 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,400 shares Expires 2019-04-23 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 52,000 | $0.00 Strike: $44.30 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 13 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,000 shares Expires 2018-02-28 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 40,800 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 12 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,800 shares Expires 2017-03-01 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $35.09 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 11 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2016-03-02 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $31.84 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 10 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2015-02-24 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 21,750 | $0.00 Strike: $48.24 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 9 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,750 shares Expires 2014-02-26 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 42,200 | $0.00 Strike: $55.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 8 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,200 shares Expires 2013-04-30 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 31,650 | $0.00 Strike: $52.28 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 7 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,650 shares Expires 2013-03-24 F4 · price: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. F4 · derivative.exercise_date: This option vests in three equal annual installments beginning one year from date of grant, was assumed in the Transaction and continued on the same terms and conditions for an option to purchase an equivalent number of shares of MSD common stock at the same exercise price as applied prior to the merger. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRSU - Leader Shares · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 6 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2012-04-24 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 5 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2012-04-24 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 9,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,750 shares Expires 2011-02-28 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 7,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,650 shares Expires 2010-03-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. Common Stock which was assumed and converted from a restricted stock unit to receive an equivalent number of shares of MSD common stock prior to the Transactions. The restricted stock units described herein vest upon the same vesting schedule. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | OtherCommon Stock - 401(k) Plan | 2,608.7358 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · nonDerivative · entry 2 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 0 F2 · price: Received as part of the Transactions in exchange for an equivalent number of shares of MSD common stock held under the MSD 401(k) plan. Read SEC document |
| November 03, 2009 Filed Nov 6, 2009 00:06 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 26,167.8585 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-051305 · c92126_4x0.xml · nonDerivative · entry 1 Scalet J Chris · CIK 0001348912 · Exe. VP, Global Services & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Received in exchange for an equivalent number of shares of Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) ("MSD") common stock in connection with the completion of transactions contemplated by the Agreement and Plan of Merger by and among, inter alia, MSD and Merck & Co., Inc. (formerly Schering-Plough Corporation) (the "Transactions"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.